 CTLA-0 is mainly expressed on the surface of activated T cells and regulates the activation of T lymphocytes at the early stages of the tumor immune cycle ([Figure 0](#F0000){ref-type="fig"}). By binding to ligand B0-0/B0-0, and CTLA-0 suppresses the activity of T cells and facilitates tumor immune escape